All Disease Treatment & Prevention articles – Page 2
-
NewsScientists discover why shingles pain can last after virus is gone
Researchers have discovered that small particles in the blood called exosomes are the likely culprit behind why some people with shingles experience lingering pain long after virus has cleared their body.The study investigated the cause of post-herpetic neuralgia (PHN) in patients infected with the varicella zoster virus.
-
NewsFecal microbiota transplantation may improve immunotherapy-related colitis
Targeting the gut microbiome with fecal microbiota transplantation may help cancer patients with immunotherapy-related colitis avoid the need for steroids and other immune-suppressing treatments, according to researchers.
-
NewsWhen antiviral defense and autoimmunity collide: New insights into lupus genetics
Researchers have found that a common lupus-associated genetic variant may strengthen antiviral immune responses while increasing the risk of autoimmunity.
-
NewsThe Wistar Institute wins $15M+ NIH investment to advance HIV cure research strategies
The Wistar Institute has announced the National Institutes of Health (NIH) has awarded two major grants totaling more than $15M to Luis J. Montaner, D.V.M., D.Phil., director of Wistar’s HIV Cure and Viral Diseases Center.
-
NewsPaper reveals huge enthusiasm for Caribbean microbiome hub at inaugural symposium
Turnout at a recent symposium has confirmed the appetite for a new microbiome hub in Puerto Rico, reveals Puerto Rico AMI Global Ambassador Dr. Filipa Godoy-Vitorino.
-
NewsGut, airway and tumor microbes emerge as promising predictors of immunotherapy response in lung cancer
A comprehensive review systematically evaluates the microbiome’s role in lung cancer immunotherapy. Authors synthesized evidence covering microbial communities in the oral cavity, airways, lung tumors and gut, and their connections to treatment efficacy and immune‑related adverse events.
-
NewsFusobacterium nucleatum drives immunosuppression and metastasis in TNBC
A new study identifies Fusobacterium nucleatum, a Gram-negative anaerobic bacterium associated with several cancers, as a key driver of tryptophan metabolic reprogramming, immunosuppression and lung metastasis in triple-negative breast cancer.
-
NewsExpert consensus outlines 12 recommendations to prevent secondary mucormycosis after respiratory viral infections
The recommendations focus on defined high-risk patients, early viral testing and treatment, hospital infection control, and practical measures for resource-limited settings.
-
NewsNew research offers avenue to explore relationship between Alzheimer’s and HIV
Researchers have created an animal model that helps resolve questions about the relationship between HIV and Alzheimer’s disease (AD). The virus that drives the root cause of AD initiates a complex chain that, with other disease partners, drives nerve cell injury and cognitive impairments for AD pathology.
-
NewsBacterial trial fails to demonstrate early asthma prevention - prompting rethink of 'hygiene hypothesis'
A national clinical trial has found that treating young children with an oral bacterial extract did not reduce the risk of severe wheezing and respiratory illnesses that can precede asthma, potentially prompting researchers to rethink aspects of the hygiene hypothesis.
-
NewsHigh-dose flu vaccine beneficial for older people with lung disease
The risk of being hospitalised for flu or pneumonia can be reduced with a high-dose flu vaccine for older people with chronic lung disease, according to the combined results of two large clinical trials.
-
NewsHaving COVID-19 is associated with lower subsequent development of type 1 diabetes among those aged under 30 years
New research shows that people who have had COVID-19 have a lower, rather than higher, risk of subsequent development of type 1 diabetes (T1D). Furthermore, the effect is evident only in people who did not receive the SARS-CoV-2 vaccine.
-
NewsSmall bowel microbiome offers clues to women’s health
A new study has identified differences in the makeup and organization of the small bowel microbiome between women and men. One intriguing finding was a bacterial community containing Granulicatella, found only in women.
-
NewsKazakh researchers ID antiviral and anti-inflammatory compounds in native medicinal plants
Researchers have identified biologically active compounds with antiviral, antimicrobial, and anti-inflammatory effects in several plant species native to Kazakhstan, providing new chemical and experimental data on medicinal flora from Central Asia.
-
NewsScientists discover link between gut bacteria and severe liver disease
Researchers have identified what may potentially be a missing link between specific activities in gut bacteria and the liver disease primary sclerosing cholangitis: the metabolite ImP, a molecule formed when certain gut bacteria break down dietary components.
-
NewsVaricella zoster virus can cause serious disease beyond chickenpox and shingles
New research is shedding light on the surprisingly broad range of neurological and systemic diseases that can be caused by varicella zoster virus (VZV), the virus that causes chickenpox and shingles.
-
NewsIndy gene reduction linked to healthier gut microbiota and longer lifespan in fruit flies
Scientists investigating aging have shown that Indy reduction is associated with lower bacterial load and higher bacterial diversity in aging Indy flies compared to controls.
-
NewsBacterial nanoplatform targets spleen to reprogram immune cells and prevent cancer recurrence
Researchers have announced the development of an engineered nanoplatform named t-SMC, which precisely targets the spleen to reverse splenic myelopoiesis toward an antitumoral immune phenotype.
-
NewsImmune drug anifrolumab linked to lower risk of infection and hospitalization for skin lupus
Preliminary results from an investigator-initiated single-site clinical study show that some people with chronic cutaneous lupus erythematosus are less likely to acquire life-threatening infections when taking the drug anifrolumab.
-
NewsScientists uncover shared biology behind profound fatigue in five major illnesses
New research identifies a shared biological secret that helps explain chronic exhaustion in conditions including long Covid and PTSD.